Diabetes mellitus after therapy with recombinant human growth hormone (rhGH).
An eight-year-old boy developed diabetes mellitus (DM) after kidney transplantation. This boy had previously been treated with recombinant human growth hormone (rhGH) for short stature due to chronic renal failure. An impaired glucose tolerance was documented after one year of rhGH treatment. An oral glucose tolerance test returned to normal six months after the discontinuation of rhGH. The boy was treated again with rhGH for seven months until his transplantation. A high fever with an enlargement of the parotid gland was noted and signs of acute rejection appeared two weeks post-transplantation. Two months after transplantation, overt DM had developed, and he was treated with insulin. The insulin dose was progressively decreased and was discontinued eight months after transplantation.
Stefanidis
C J
CJ
A Kyriakou Children's Hospital, Athens, Greece.
Papathanassiou
A
A
Michelis
K
K
Theodoridis
X
X
Papachristou
F
F
Sotiriou
J
J
D002648:Child; D003920:Diabetes Mellitus / Q000139:chemically induced*; D006130:Growth Disorders / Q000188:drug therapy; D019382:Human Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D011184:Postoperative Period
D019382:Human Growth Hormone